Suzanne Ostrand-Rosenberg
9Patents
5h-index
7Co-inventors
56Inventor score
Filing activity: Nov 3, 1993 → Apr 20, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5858776A | Tumor cells with increased immunogenicity and uses therefor | Human Necessities | 33 | Expired |
| US8956619B2 | Soluble CD80 as a therapeutic to reverse immune supression in cancer patients | Chemistry; Metallurgy | 25 | Active |
| US9650429B2 | Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients | Chemistry; Metallurgy | 19 | Active |
| US6149905A | Tumor cells with increased immunogenicity and uses therefor | Human Necessities | 15 | Expired |
| US6319709A | Tumor cells with increased immunogenicity and uses therefor | Human Necessities | 13 | Expired |
| US8026224B2 | Tumor cells with increased immunogenicity and uses therfor | Human Necessities | 1 | Active |
| US7807186B2 | Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines | Human Necessities | 1 | Active |
| US10377810B2 | Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients | Chemistry; Metallurgy | 0 | Active |
| US8444965B2 | Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.